Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tellgen Corporation (300642.SZ)
CNY13.37
+0.83 (+6.62%)
CN SHZ Healthcare Medical - Devices
Address
Building 1 201203
Shanghai, CN
Shanghai, CN
CEO
Jian Er Yao
Website
tellgen.com
IPO
2017-04-21
ISIN CNE100002P42
Description
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CNY13.37
+0.83 (+6.62%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.30
Float Shares
145.89M
Free Float %
89.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.41% | -8.58% | -15.51% | -24.92% | -29.19% | -24.14% | -0.50% | -34.29% | -66.96% | -27.53% | -27.53% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
13.37
DCF (Unlevered)
4.76
-64.4%
DCF (Levered)
17.49
+30.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.67
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-16.7% Q1'26: +10.3% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-89.5% Q1'26: -1,300.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+11.6% Q1'26: -2.0% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-0.1% Q1'26: -2.5% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%0.0% Q1'26: -0.6% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+0.6% Q1'26: -1.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×6.58× ★ Q1'26: -46.78× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
302.89M
est: 312.20M (-3.0%)
|
364.85M
est: 365.00M (0.0%)
|
441.45M
est: 455.00M (-3.0%)
|
489.58M
est: 489.60M (0.0%)
|
654.59M
est: 699.00M (-6.4%)
|
715.60M
est.
|
715.97M
est: 607.04M (+17.9%)
|
542.81M
est: 607.04M (-10.6%)
|
436.78M
est: 711.05M (-38.6%)
|
363.83M
est: 891.93M (-59.2%)
|
511.00M
511.00M – 511.00M
-42.7% YoY
|
| EBITDA |
171.43M
est: 100.23M (+71.0%)
|
197.50M
est: 117.18M (+68.5%)
|
224.25M
est: 146.08M (+53.5%)
|
186.03M
est: 157.18M (+18.4%)
|
246.35M
est: 224.41M (+9.8%)
|
229.74M
est.
|
206.92M
est: 194.89M (+6.2%)
|
161.50M
est: 194.89M (-17.1%)
|
98.30M
est: 192.21M (-48.9%)
|
59.54M
est: 241.11M (-75.3%)
|
138.13M
138.13M – 138.13M
-42.7% YoY
|
| EBIT |
147.54M
est: 59.11M (+149.6%)
|
165.35M
est: 69.11M (+139.3%)
|
181.26M
est: 86.15M (+110.4%)
|
130.63M
est: 92.70M (+40.9%)
|
179.46M
est: 132.34M (+35.6%)
|
135.48M
est.
|
131.52M
est: 114.93M (+14.4%)
|
88.34M
est: 114.93M (-23.1%)
|
36.38M
est: 99.97M (-63.6%)
|
-317.6K
est: 125.41M (-100.3%)
|
71.85M
71.85M – 71.85M
-42.7% YoY
|
| Net Income |
126.81M
est: 126.39M (+0.3%)
|
141.69M
est: 142.19M (-0.4%)
|
157.02M
est: 160.97M (-2.5%)
|
120.55M
est: 120.73M (-0.1%)
|
161.08M
est: 169.02M (-4.7%)
|
112.68M
est.
|
124.76M
est: 106.24M (+17.4%)
|
89.40M
est: 106.24M (-15.8%)
|
34.53M
est: 136.99M (-74.8%)
|
3.59M
est: 185.92M (-98.1%)
|
—
— – —
-100.0% YoY
|
| SGA |
76.91M
est: 23.69M (+224.6%)
|
106.52M
est: 27.70M (+284.6%)
|
131.98M
est: 34.53M (+282.2%)
|
147.83M
est: 37.15M (+297.9%)
|
225.25M
est: 53.05M (+324.6%)
|
54.31M
est.
|
231.81M
est: 46.07M (+403.2%)
|
206.98M
est: 46.07M (+349.3%)
|
162.23M
est: 215.79M (-24.8%)
|
35.21M
est: 270.68M (-87.0%)
|
155.08M
155.08M – 155.08M
-42.7% YoY
|
| EPS |
0.85
est: 0.79 (+8.3%)
|
0.87
est: 0.88 (-1.5%)
|
0.97
est: 1.00 (-3.0%)
|
0.74
est: 0.75 (-1.3%)
|
0.99
est: 1.05 (-5.7%)
|
0.70
est.
|
0.77
est: 0.66 (+16.7%)
|
0.55
est: 0.66 (-16.7%)
|
0.21
est: 0.84 (-75.0%)
|
0.02
est: 1.14 (-98.1%)
|
—
— – —
-100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
22.52M
OE per share TTM
0.14
Owner's Yield
1.01%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
64.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-608.00
Shares Outstanding
162.54M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| En Huan Yang | Deputy GM & Non-Independent Director | — | male |
| Jian Er Yao | Non-Independent Chairman of Board & GM | — | male |
| Songtao Li | Financial Manager & Accounting Supervisor | — | male |
| Xiaoqing Wang | Deputy GM, Secretary of Board of Directors, Director of GM's Office & Non-Independent Director | — | male |
| Ye Sheng | Director of R&D and Deputy GM | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300642.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
